Tearsheet

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -15%

Low stock price volatility
Vol 12M is 40%

Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Health & Wellness Trends. Themes include Geriatric Care, Preventative Healthcare, Show more.

Weak multi-year price returns
2Y Excs Rtn is -90%, 3Y Excs Rtn is -125%

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 184x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 30x, P/EPrice/Earnings or Price/(Net Income) is 38x

Significant short interest
Short Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 31.18

Key risks
JYNT key risks include [1] a history of financial restatements and material weaknesses in internal controls and [2] decelerating growth fueled by marketing inefficiency and high SG&A expenses.

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -15%
1 Low stock price volatility
Vol 12M is 40%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Health & Wellness Trends. Themes include Geriatric Care, Preventative Healthcare, Show more.
3 Weak multi-year price returns
2Y Excs Rtn is -90%, 3Y Excs Rtn is -125%
4 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 184x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 30x, P/EPrice/Earnings or Price/(Net Income) is 38x
5 Significant short interest
Short Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 31.18
6 Key risks
JYNT key risks include [1] a history of financial restatements and material weaknesses in internal controls and [2] decelerating growth fueled by marketing inefficiency and high SG&A expenses.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Joint (JYNT) stock has lost about 10% since 1/31/2026 because of the following key factors:

1. Declining System-Wide and Comparable Sales Indicates Weakened Demand. The Joint Corp. experienced a significant decline in its system-wide sales, which fell by 4.9% to $126.1 million in the first quarter of 2026 compared to the same period in 2025. Additionally, comparable sales for clinics open 13 months or more decreased by 4.2%. This reduction in overall sales across its network signals a softening in customer demand for chiropractic services.

2. Strategic Refranchising Initiatives Lead to Short-Term Clinic Count Reduction. While the company is undergoing a strategic "Joint 2.0" transformation to become a pure-play franchisor, this transition has resulted in a net decrease in the total clinic count. The total number of clinics decreased from 960 at December 31, 2025, to 943 at March 31, 2026, due to 20 clinic closures offsetting three openings. In April 2026, the company signed an agreement to sell 45 company-owned clinics for $2.3 million, further reducing corporate footprint, which, despite aiming for long-term profitability, can create near-term investor uncertainty regarding growth metrics.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The -11.1% change in JYNT stock from 1/31/2026 to 5/10/2026 was primarily driven by a -51.0% change in the company's P/E Multiple.
(LTM values as of)13120265102026Change
Stock Price ($)9.788.69-11.1%
Change Contribution By: 
Total Revenues ($ Mil)54574.0%
Net Income Margin (%)3.6%5.7%61.0%
P/E Multiple77.638.1-51.0%
Shares Outstanding (Mil)15148.2%
Cumulative Contribution-11.1%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 5/10/2026
ReturnCorrelation
JYNT-11.1% 
Market (SPY)3.6%35.9%
Sector (XLV)-6.9%16.6%

Fundamental Drivers

The 10.1% change in JYNT stock from 10/31/2025 to 5/10/2026 was primarily driven by a 8.1% change in the company's Shares Outstanding (Mil).
(LTM values as of)103120255102026Change
Stock Price ($)7.898.6910.1%
Change Contribution By: 
Total Revenues ($ Mil)54575.4%
P/S Multiple2.32.2-3.3%
Shares Outstanding (Mil)15148.1%
Cumulative Contribution10.1%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 5/10/2026
ReturnCorrelation
JYNT10.1% 
Market (SPY)5.5%32.3%
Sector (XLV)0.3%30.3%

Fundamental Drivers

The -13.2% change in JYNT stock from 4/30/2025 to 5/10/2026 was primarily driven by a -24.2% change in the company's P/S Multiple.
(LTM values as of)43020255102026Change
Stock Price ($)10.018.69-13.2%
Change Contribution By: 
Total Revenues ($ Mil)52578.6%
P/S Multiple2.92.2-24.2%
Shares Outstanding (Mil)15145.5%
Cumulative Contribution-13.2%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2025 to 5/10/2026
ReturnCorrelation
JYNT-13.2% 
Market (SPY)30.4%31.7%
Sector (XLV)4.0%23.1%

Fundamental Drivers

The -45.0% change in JYNT stock from 4/30/2023 to 5/10/2026 was primarily driven by a -89.6% change in the company's P/E Multiple.
(LTM values as of)43020235102026Change
Stock Price ($)15.798.69-45.0%
Change Contribution By: 
Total Revenues ($ Mil)10157-44.1%
Net Income Margin (%)0.6%5.7%823.8%
P/E Multiple366.138.1-89.6%
Shares Outstanding (Mil)15142.5%
Cumulative Contribution-45.0%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2023 to 5/10/2026
ReturnCorrelation
JYNT-45.0% 
Market (SPY)78.7%30.2%
Sector (XLV)13.0%23.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
JYNT Return150%-79%-31%11%-18%-1%-67%
Peers Return14%-31%-9%23%-14%25%-4%
S&P 500 Return27%-19%24%23%16%7%95%

Monthly Win Rates [3]
JYNT Win Rate58%25%33%58%58%60% 
Peers Win Rate50%38%40%55%42%40% 
S&P 500 Win Rate75%42%67%75%67%60% 

Max Drawdowns [4]
JYNT Max Drawdown0%-80%-47%-7%-28%-6% 
Peers Max Drawdown-14%-43%-29%-17%-28%-25% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: USPH, SEM, PLNT, LTH, XWEL. See JYNT Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/8/2026 (YTD)

How Low Can It Go

EventJYNTS&P 500
2025 US Tariff Shock
  % Loss-15.3%-18.8%
  % Gain to Breakeven18.0%23.1%
  Time to Breakeven45 days79 days
2024 Yen Carry Trade Unwind
  % Loss-10.7%-7.8%
  % Gain to Breakeven12.0%8.5%
  Time to Breakeven223 days18 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-44.4%-9.5%
  % Gain to Breakeven80.0%10.5%
  Time to Breakeven176 days24 days
2023 SVB Regional Banking Crisis
  % Loss-14.9%-6.7%
  % Gain to Breakeven17.5%7.1%
  Time to Breakeven315 days31 days
2020 COVID-19 Crash
  % Loss-51.4%-33.7%
  % Gain to Breakeven105.8%50.9%
  Time to Breakeven82 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-22.3%-19.2%
  % Gain to Breakeven28.7%23.7%
  Time to Breakeven56 days105 days

Compare to USPH, SEM, PLNT, LTH, XWEL

In The Past

Joint's stock fell -15.3% during the 2025 US Tariff Shock. Such a loss loss requires a 18.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventJYNTS&P 500
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-44.4%-9.5%
  % Gain to Breakeven80.0%10.5%
  Time to Breakeven176 days24 days
2020 COVID-19 Crash
  % Loss-51.4%-33.7%
  % Gain to Breakeven105.8%50.9%
  Time to Breakeven82 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-22.3%-19.2%
  % Gain to Breakeven28.7%23.7%
  Time to Breakeven56 days105 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-64.8%-12.2%
  % Gain to Breakeven183.8%13.9%
  Time to Breakeven820 days62 days
2014-2016 Oil Price Collapse
  % Loss-43.9%-6.8%
  % Gain to Breakeven78.3%7.3%
  Time to Breakeven776 days15 days

Compare to USPH, SEM, PLNT, LTH, XWEL

In The Past

Joint's stock fell -15.3% during the 2025 US Tariff Shock. Such a loss loss requires a 18.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Joint (JYNT)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

AI Analysis | Feedback

Here are a few analogies for The Joint Corp. (JYNT):

  • The Great Clips of chiropractic clinics.
  • A Starbucks for chiropractic adjustments.

AI Analysis | Feedback

```html
  • Chiropractic Care: Direct provision of chiropractic adjustments and related services to patients through its network of clinics.
  • Franchise Operations: Offering opportunities to individuals and entities to own and operate chiropractic clinics under The Joint Corp. brand and system.
  • Clinic Management and Support: Providing operational, developmental, and support services for both corporate-owned and franchised chiropractic clinics.
```

AI Analysis | Feedback

The Joint Corp. (JYNT) operates chiropractic clinics, which provide direct healthcare services to individuals. Therefore, the company primarily sells its services to individuals.

The major categories of individual customers served by The Joint Corp. include:

  1. Individuals seeking pain relief: This category encompasses patients experiencing acute or chronic musculoskeletal pain, such as back pain, neck pain, headaches, and sciatica, who seek chiropractic adjustments for symptom alleviation and recovery.
  2. Individuals seeking wellness and preventative care: Customers in this group may not be experiencing acute pain but choose chiropractic care for ongoing spinal health maintenance, improved posture, stress reduction, and overall well-being. They often receive regular, routine adjustments.
  3. Athletes and active individuals: This segment includes people who use chiropractic services for performance enhancement, injury prevention, faster recovery from physical activity, and to maintain optimal bodily function to support their active lifestyles.

AI Analysis | Feedback

null

AI Analysis | Feedback

Sanjiv Razdan, Chief Executive Officer

Sanjiv Razdan joined The Joint in 2024, bringing over 35 years of experience in franchising and hospitality. He has a strong background in growing and leading successful multi-unit companies and franchise businesses. Before joining The Joint, he was President of Americas and India for The Coffee Bean & Tea Leaf, a global specialty coffee and tea house company. Razdan also held senior operations leadership roles at prominent franchisors such as Yum! Brands (Pizza Hut and KFC), Dine Brands (Applebee's), and Sweetgreen. He earned a Bachelor of Science degree in Physics and Computer Science from St. Xavier's College in Mumbai, India, completed a post-graduate program in Hotel Administration with ITC Hotels, and holds a certificate from Cornell University in QSR Management.

Scott J. Bowman, Chief Financial Officer

Scott J. Bowman became Chief Financial Officer of The Joint Corp. on June 10, 2025. He is a seasoned executive and a three-time public company CFO, with over 30 years of experience across the retail, restaurant, consumer goods, and manufacturing industries. Prior to The Joint, Bowman served as CFO at Leslie's Inc., a publicly held pool supply retailer (2023-2025), True Food Kitchen, a privately held restaurant company (2021-2023), Dave & Buster's, a publicly held dining and entertainment company (2019-2021), and Hibbett Sports, a publicly held athletic specialty retailer (2012-2019) that was subsequently acquired by JD Sports. For over two decades prior, he held roles of increasing responsibility in the finance and accounting departments at The Home Depot, divisions of Newell Rubbermaid, and The Sherwin-Williams Company. Bowman holds a B.S. in Accounting and Finance from Miami University (Ohio) and an MBA from Emory Goizueta Business School, and is a CPA.

Ron Stilwell, Senior Vice President Operations and Patient Experience

Ron Stilwell joined The Joint in 2026. He has successfully utilized his expertise in franchise operations, P&L management, and customer satisfaction to help franchisors grow and maximize profitability. Before his tenure at The Joint, Stilwell served as President and Chief Development Officer of FullSpeed Automotive, a significant automotive aftermarket conglomerate that operates and franchises quick oil change and service centers, starting in 2021.

Beth Gross, Vice President of Human Resources

Beth Gross joined The Joint in September 2024, bringing over two decades of human resources experience. Most recently, she held the position of Vice President of Human Resources at Spear Education, a private equity-owned dental education organization based in Scottsdale, Arizona. In this role, she managed all aspects of organizational development and talent acquisition strategy, and established the employer branding strategy, under which Spear Education was recognized five times as a "Top Companies to Work For in AZ". Gross earned a BA in corporate communications from Arizona State University.

Craig Sherwood, Chief Development Officer

Craig Sherwood joined The Joint in 2025. He has more than 25 years of executive leadership experience in global franchise development within both the fitness and Quick Service Restaurant (QSR) industries. Before joining The Joint, he was the Chief Development Officer for Lumin Fitness, an AI-powered fitness company, where he was responsible for all aspects of Lumin's global franchise development, real estate, design, and construction, and he initiated the strategic direction for the brand.

AI Analysis | Feedback

The Joint Corp. (JYNT) faces several key risks, primarily stemming from its business model transformation and external economic and regulatory pressures.

1. Reliance on the Franchise Model and Franchisee Performance

The Joint Corp. is undergoing a strategic transition to become a "pure-play franchisor," divesting its company-owned clinics. This shift makes the company's financial performance and brand reputation highly dependent on the success and operational consistency of its franchisees. Risks associated with this model include the potential for franchisees to underperform, which directly impacts royalty revenue and could lead to inconsistencies in service quality across locations due to the franchisor's limited control over independent operators. The company's historical disclosures regarding franchise health and the challenges of expansion into new states have also been noted as potential concerns.

2. Labor Shortages and Inflationary Pressures

The company is vulnerable to nationwide labor shortages, particularly in recruiting qualified chiropractors and other staff, which can lead to increased operating costs and even reduced revenues. Inflation further exacerbates this risk by driving up labor expenses and interest rates. Additionally, inflationary pressures could lead to reduced discretionary spending by consumers on services such as chiropractic care, negatively impacting patient volumes and revenue.

3. Regulatory and Legal Risks

The Joint Corp. operates within a highly regulated healthcare industry, with chiropractic practice subject to varying state-level laws, particularly concerning the "corporate practice of chiropractic". Challenges to the company's management agreements with chiropractic professional corporations could significantly disrupt its business model in certain regions. The company has previously faced regulatory inquiries in multiple states, indicating an ongoing threat from evolving state and federal regulations.

AI Analysis | Feedback

The clear emerging threat to The Joint Corp. is the rapid growth and adoption of Digital Therapeutics (DTx) and virtual physical therapy platforms specifically targeting musculoskeletal (MSK) pain management. Companies in this space offer remotely delivered, personalized exercise programs, coaching, and education for conditions like back and neck pain, often covered by employers and health plans. These platforms provide an accessible, non-invasive, and often more cost-effective alternative to in-person chiropractic care, directly competing for a significant portion of The Joint's target market seeking relief and management for MSK issues.

AI Analysis | Feedback

The addressable market for The Joint Corp.'s main product or service, chiropractic care, is the United States.

The U.S. chiropractic market size was approximately USD 13.13 billion in 2022. It reached an estimated USD 21.4 billion in 2024 and is projected to be USD 21.9 billion in 2025. The market is predicted to grow to around USD 18.40 billion by 2030.

AI Analysis | Feedback

The Joint Corp. (JYNT) is anticipated to drive future revenue growth over the next 2-3 years through several strategic initiatives:

  1. Expansion of the Franchise Network and New Clinic Openings: The company is transitioning to a pure-play franchisor model, actively refranchising corporate clinics and focusing on opening new franchised units. This shift is expected to increase franchise royalties and fees. The Joint Corp. aims to complete this transition by 2026, with plans for 30-35 new franchised clinic openings in 2026.

  2. Strategic Pricing Adjustments: The Joint Corp. has implemented a new pricing strategy, incorporating smaller, more frequent price increases and introducing a "Kickstart plan" for supplemental adjustments. These initiatives are designed to enhance revenue per patient visit.

  3. Enhanced Patient Acquisition and Retention through Marketing: The company is intensifying its marketing efforts to attract new patients and improve the retention of existing members. This includes refining brand positioning, media strategies, and digital visibility (SEO), with a focus on chiropractic care for pain relief, attracting lapsed patients, and extending existing memberships.

  4. Broader Market Expansion and Service Offerings: Plans include expanding operations into new markets within the U.S., with potential international expansion beginning in 2027. Additionally, the company is exploring broadening its service offerings, such as through B2B channels and integrated treatments.

AI Analysis | Feedback

Capital Allocation Decisions (Last 3-5 Years)

Share Repurchases

  • The Joint Corp. authorized a $5 million stock repurchase program in June 2025, which was expected to commence in August 2025 and conclude by June 3, 2027.
  • Following the completion of the initial $5 million buyback, the board authorized an additional $12 million for the stock repurchase program in November 2025.
  • For the full year 2025, the company repurchased 1.3 million shares totaling $11.3 million. As of December 31, 2025, $5.7 million remained authorized under the $12 million program.

Capital Expenditures

  • In the first half of 2023, The Joint Corp. invested $4.7 million in the development of greenfield clinics, improvements to existing clinics, the acquisition of a previously owned franchise, and the reacquisition of regional developer territories.
  • The company is undergoing a strategic transformation to become a "pure-play franchisor," which involves refranchising corporate-owned clinics. This strategy aims to shift towards a more capital-light operating model.
  • For a pure-play franchisor model, capital expenditures are projected to be approximately 3% of revenues at an expected mid-2026 run rate.

Better Bets vs. Joint (JYNT)

Trade Ideas

Select ideas related to JYNT.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
GEHC_4302026_Dip_Buyer_FCFYield04302026GEHCGE HealthCare TechnologiesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
0.0%0.0%0.0%
IQV_4302026_Dip_Buyer_FCFYield04302026IQVIQVIADip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
0.0%0.0%0.0%
UHS_4302026_Dip_Buyer_FCFYield04302026UHSUniversal Health ServicesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
0.0%0.0%0.0%
ABT_4302026_Dip_Buyer_ValueBuy04302026ABTAbbott LaboratoriesDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
0.0%0.0%0.0%
ZBIO_4302026_Insider_Buying_45D_2Buy_200K04302026ZBIOZenas BioPharmaInsiderInsider Buys 45DStrong Insider Buying
Companies with multiple insider buys in the last 45 days
0.0%0.0%0.0%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
Mkt Price8.6959.2916.4145.8831.931.4724.17
Mkt Cap0.10.92.03.77.10.01.4
Rev LTM577815,5211,3853,078291,083
Op Inc LTM180322414508-9201
FCF LTM361152267-124-1232
FCF 3Y Avg466251228-57-1435
CFO LTM475388432885-9231
CFO 3Y Avg677478381678-12229

Growth & Margins

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
Rev Chg LTM6.8%16.3%5.8%14.4%12.7%-13.8%9.7%
Rev Chg 3Y Avg2.5%12.2%6.0%12.5%16.6%-15.8%9.1%
Rev Chg Q13.3%12.3%5.0%21.9%11.7%-4.2%12.0%
QoQ Delta Rev Chg LTM3.2%2.9%1.3%4.6%2.8%-1.1%2.8%
Op Inc Chg LTM132.3%22.6%22.6%22.7%29.3%22.7%22.7%
Op Inc Chg 3Y Avg-150.8%7.5%18.8%21.1%40.7%27.2%19.9%
Op Mgn LTM1.2%10.3%5.8%29.9%16.5%-32.0%8.1%
Op Mgn 3Y Avg-0.4%10.6%5.4%28.0%13.6%-43.8%8.0%
QoQ Delta Op Mgn LTM2.8%0.4%-0.3%0.1%0.5%1.9%0.4%
CFO/Rev LTM7.2%9.6%7.0%31.2%28.8%-29.8%8.4%
CFO/Rev 3Y Avg16.6%11.4%9.5%30.9%24.7%-38.6%14.0%
FCF/Rev LTM4.7%7.8%2.8%19.3%-4.0%-40.0%3.7%
FCF/Rev 3Y Avg10.5%9.9%5.0%18.5%-2.4%-46.3%7.4%

Valuation

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
Mkt Cap0.10.92.03.77.10.01.4
P/S2.21.20.42.62.30.31.7
P/Op Inc183.911.26.28.813.9-0.910.0
P/EBIT183.910.35.38.413.9-0.59.3
P/E38.159.714.816.018.4-0.517.2
P/CFO30.312.05.18.58.0-1.08.2
Total Yield2.6%3.2%8.3%6.3%5.4%-199.5%4.3%
Dividend Yield0.0%1.5%1.6%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg2.3%5.2%10.4%3.6%-2.1%-224.8%2.9%
D/E0.00.41.50.80.61.50.7
Net D/E-0.20.31.50.70.61.20.6

Returns

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
1M Rtn-0.5%-22.5%0.2%-34.8%14.2%23.5%-0.1%
3M Rtn-10.6%-30.3%5.0%-49.9%7.1%259.4%-2.8%
6M Rtn13.3%-18.8%24.2%-56.9%25.1%75.0%18.7%
12M Rtn-13.0%-18.0%12.0%-50.6%12.2%67.0%-0.5%
3Y Rtn-40.3%-43.4%11.0%-33.8%55.8%-69.8%-37.0%
1M Excs Rtn-9.9%-31.4%-8.2%-45.1%5.5%11.1%-9.0%
3M Excs Rtn-17.3%-37.0%-1.7%-56.6%0.3%252.7%-9.5%
6M Excs Rtn-4.0%-40.7%14.0%-58.8%16.9%56.3%5.0%
12M Excs Rtn-44.0%-45.8%-20.1%-86.3%-34.5%47.4%-39.3%
3Y Excs Rtn-125.1%-121.6%-73.7%-124.6%-22.0%-150.5%-123.1%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Franchise operations52    
Total52    


Net Income by Segment
$ Mil20252024202320222021
Franchise operations-6    
Total-6    


Price Behavior

Price Behavior
Market Price$8.69 
Market Cap ($ Bil)0.1 
First Trading Date11/11/2014 
Distance from 52W High-30.5% 
   50 Days200 Days
DMA Price$8.69$9.23
DMA Trenddowndown
Distance from DMA-0.0%-5.8%
 3M1YR
Volatility31.7%39.4%
Downside Capture0.810.63
Upside Capture76.0769.44
Correlation (SPY)33.0%30.2%
JYNT Betas & Captures as of 4/30/2026

 1M2M3M6M1Y3Y
Beta1.050.730.800.881.031.02
Up Beta0.570.860.710.600.960.75
Down Beta-0.970.09-0.070.461.091.11
Up Capture90%79%87%126%74%77%
Bmk +ve Days15223166141428
Stock +ve Days15253566122336
Down Capture475%85%123%105%121%108%
Bmk -ve Days4183056108321
Stock -ve Days7182957123397

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with JYNT
JYNT-12.5%40.1%-0.24-
Sector ETF (XLV)7.9%15.4%0.3024.9%
Equity (SPY)29.0%12.5%1.8330.9%
Gold (GLD)39.8%27.0%1.22-7.8%
Commodities (DBC)50.6%18.0%2.21-16.0%
Real Estate (VNQ)13.0%13.5%0.6622.2%
Bitcoin (BTCUSD)-17.4%42.1%-0.3414.5%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with JYNT
JYNT-30.9%58.4%-0.40-
Sector ETF (XLV)4.9%14.6%0.1626.2%
Equity (SPY)12.8%17.1%0.5938.8%
Gold (GLD)20.9%17.9%0.952.0%
Commodities (DBC)13.8%19.1%0.593.0%
Real Estate (VNQ)3.4%18.8%0.0833.9%
Bitcoin (BTCUSD)7.0%56.0%0.3423.7%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with JYNT
JYNT10.1%57.1%0.41-
Sector ETF (XLV)9.3%16.5%0.4625.6%
Equity (SPY)15.1%17.9%0.7235.5%
Gold (GLD)13.4%15.9%0.690.3%
Commodities (DBC)9.3%17.8%0.449.5%
Real Estate (VNQ)5.8%20.7%0.2432.2%
Bitcoin (BTCUSD)67.8%66.9%1.0713.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date4152026
Short Interest: Shares Quantity0.9 Mil
Short Interest: % Change Since 33120265.1%
Average Daily Volume0.0 Mil
Days-to-Cover Short Interest31.2 days
Basic Shares Quantity14.2 Mil
Short % of Basic Shares6.6%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
3/12/20262.3%-0.5%8.0%
11/6/2025-3.9%3.5%9.3%
7/30/2025-4.0%-3.2%-7.2%
5/8/2025-5.1%-4.0%13.2%
1/16/20251.7%2.6%4.8%
11/7/2024-2.3%-5.6%-2.9%
8/8/2024-8.4%-5.7%-10.2%
3/7/202430.0%29.1%41.2%
...
SUMMARY STATS   
# Positive111011
# Negative9109
Median Positive3.7%10.6%13.2%
Median Negative-5.1%-4.8%-16.3%
Max Positive30.0%29.1%41.2%
Max Negative-37.9%-40.0%-41.8%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/08/202610-Q
12/31/202503/13/202610-K
09/30/202511/07/202510-Q
06/30/202508/12/202510-Q
03/31/202505/09/202510-Q
12/31/202403/14/202510-K
09/30/202411/08/202410-Q
06/30/202408/09/202410-Q
03/31/202405/03/202410-Q
12/31/202303/08/202410-K
09/30/202311/13/202310-Q
06/30/202309/26/202310-Q
03/31/202305/05/202310-Q
12/31/202203/10/202310-K
09/30/202211/04/202210-Q
06/30/202208/05/202210-Q

Recent Forward Guidance [BETA]

Latest: Q1 2026 Earnings Reported 5/7/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 System-wide sales519.00 Mil535.50 Mil552.00 Mil0.6% AffirmedActual: 532.40 Mil for 2025
2026 System-wide comp sales-0.0300.03 0.4%AffirmedActual: -0 for 2025
2026 Consolidated Adjusted EBITDA12.50 Mil13.00 Mil13.50 Mil0.0% AffirmedActual: 13.00 Mil for 2025
2026 New franchised clinic openings3032.53512.1% AffirmedActual: 29 for 2025

Prior: Q4 2025 Earnings Reported 3/12/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 System-wide sales519.00 Mil535.50 Mil552.00 Mil0.6% Higher NewActual: 532.40 Mil for 2025
2026 System-wide comp sales-0.0300.03 0.4%Higher NewActual: -0 for 2025
2026 Consolidated Adjusted EBITDA12.50 Mil13.00 Mil13.50 Mil0.0% Same NewActual: 13.00 Mil for 2025
2026 New franchised clinic openings3032.53512.1% Higher NewActual: 29 for 2025

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Jobson, Charles EDirectBuy42320268.585094,36714,120,990Form
2Jobson, Charles EDirectBuy21720268.5015,397130,87413,984,999Form
3Jobson, Charles EDirectBuy21320268.704483,89814,264,494Form
4Jobson, Charles EDirectBuy127202610.007257,25016,391,490Form
5Jobson, Charles EDirectBuy127202610.0016,753167,53016,384,240Form